A股異動丨英唐智控(300131.SZ)大漲11.74% 重組完成在即
格隆匯9月11日丨此前兩個交易日累跌逾26%的英唐智控(300131.SZ)大漲11.74%,報7.14元,總市值76.4億元。英唐智控昨晚披露重大資產出售的進展公告,公告顯示,買方英唐創泰已於當日獲得股東增資4.92億元人民幣。自此英唐創泰受讓重組標的聯合創泰100%股權的14.8億元對價中的自有資金部分5.92億元人民幣已經全部到位,英唐創泰已經完成了ODI(對外直接投資)備案程序的申報準備工作,在ODI備案程序完成後,英唐智控本次重大資產出售進程將步入快車道,整體交易完成在即。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.